Discover how teams, technology, and innovation are reshaping the future of literature monitoring and drug safety compliance.
The monitoring and prevention of adverse drug events, which forms the core of Pharmacovigilance (PV), is critical to ensure patient safety across a medication’s lifecycle…
Pharmacovigilance is by its nature a detail-driven undertaking, and within it monitoring medical literature for safety signals is notoriously labour intensive…
The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and workforce diversity…
The monitoring and prevention of adverse drug events, which forms the core of Pharmacovigilance (PV), is critical to ensure patient safety across a medication’s lifecycle…
Pharmacovigilance is by its nature a detail-driven undertaking, and within it monitoring medical literature for safety signals is notoriously labour intensive…
The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and workforce diversity…
In light of the evolving therapeutic landscape, increasing use of advanced technologies, and political shifts, regulatory updates are inevitable, meaning that bio/pharma companies will need to adjust quickly to new requirements.
Medical literature monitoring is a key part of pharmacovigilance (PV) and ultimately patient safety across the lifecycle of a medicine. Globally, the practice is relatively straightforward…
Patient safety across the lifecycle of a medicine depends on vigilant monitoring of medical literature – not just well-known global sources, but also at a local level…
Monitoring in-country medical literature is an essential aspect of pharmacovigilance, providing an early pointer to adverse events in specific populations….
The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and workforce diversity is being embraced, AI beckons as a new challenge.
Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable…
Biologit launches a world-first automation solution for local literature monitoring…
If you have been struggling with manual local literature monitoring, you’re not alone. Pharmaceutical companies worldwide face growing regulatory pressure to monitor both global and local medical…
This white paper explores the challenges, trends and opportunities offered by new technologies to deliver efficient and compliant literature processes, and how those challenges can be met today…
10 min read
A Compliance-Oriented Evaluation of Manual Versus AI-Driven Approaches a Scientific and Regulatory Perspective for Quality and Safety Professionals Abstract Medical
3 min read
Pharmacovigilance necessitates the comprehensive collection and analysis of data from diverse sources to evaluate pharmaceutical products effectively. Medical literature monitoring,
1 min read
Proven Results with biologit At biologit, we are committed to assisting our clients with their pharmacovigilance needs. Recently, we helped
1 min read
Proven Results with biologit At biologit, we are dedicated to supporting our clients with their pharmacovigilance needs. We recently supported
3 min read
For biotech and pharmaceutical companies with a clinical development program, understanding the safety and efficacy of a therapy is a
5 min read
Recently I read a report on the clinical effectiveness of an Infliximab biosimilar used as a switch from Remicade (infliximab)
2 min read
At this year’s World Drug Safety Conferences in Amsterdam and Boston, biologit presented two case studies detecting relevant safety events
9 min read
Antimicrobial Resistance: Case study from the scientific literature Antibiotic resistance is ,an inevitable biological process but as humans we accelerate
5 min read
By Naveen Basar, Biologit Product Manager Literature Surveillance: An Essential Component of Pharmacovigilance In the world of pharmacovigilance, staying ahead of potential drug safety risk
Small biotech and pharmaceutical companies in clinical development must understand and address safety risks in their compounds to ensure successful regulatory submissions. This requires the effective monitoring
Regulatory Literature Searches for Safety Information Monitoring the scientific literature is critical component in understanding the safety profile of medicines and medical devices. It is
Challenges in Pharmacovigilance Literature Monitoring With the large and growing volume of scientific literature available, automating literature monitoring activities is becoming a necessity for companies
In the ever-evolving landscape of healthcare technology, where precision and reliability are paramount, we are committed to staying current and employing the latest guidelines and
The reliable detection of duplicates in literature monitoring and other pharmacovigilance activities is widely recognised as a major challenge. Unmanaged duplicates not only result in
biologit MLM-AI is a literature monitoring platform that makes it easy for safety surveillance teams of all sizes to work together and collaborate. In this
In October 2021 the U.S. Food and Drug Administration in conjunction with Health Canada and the MHRA (UK) released guiding principles on Good Machine Learning
There is continued interest from pharmaceutical companies, solution providers, and academia in improving pharmacovigilance processes with Artificial Intelligence given the increasing volume of data to
Naveen Basar and Bruno Ohana. The Guidelines on good pharmacovigilance practices – module VI is a document issued by the European Medicines Agency outlining practices
Medical literature monitoring (MLM) for adverse drug reactions is an important aspect of the pharmacovigilance process and a regulatory requirement for medicinal products on the
Challenges of Medical Literature Monitoring for Pharmacovigilance The medical and scientific literature is an important source of information regarding safety issues of medicinal products and
At biologit we’re making transparency an integral part of our development process, and we’re excited to release the first fact sheet for biologit MLM-AI’s Suspected
The monitoring of scientific literature for adverse events is a high volume activity requiring more time from specialists every day. In this article we discuss
